GUJRAT ALKALI :Co. inform that the Patent has now been granted for the same process by the United States Patent & Trademark Office, with a Patent Number US 11225413 B2 entitled "PROCESS FOR PRODUCTION OF HYDRAZINE HYDRATE" to GACL jointly
with CSIR.
As informed earlier, 10000 TPA (80%) Hydrazine Hydrate Project, with forward integration to Hydrogen Peroxide, for the manufacturing of an import substitute at Dahej, is under implementation and it is expected to go on stream in near future.
This is a major step towards "Atmanirbhar Bharat" δΈ vision of the Hon. Prime Minister of India for making the India a self-reliant nation, in Chemical Sector
with CSIR.
As informed earlier, 10000 TPA (80%) Hydrazine Hydrate Project, with forward integration to Hydrogen Peroxide, for the manufacturing of an import substitute at Dahej, is under implementation and it is expected to go on stream in near future.
This is a major step towards "Atmanirbhar Bharat" δΈ vision of the Hon. Prime Minister of India for making the India a self-reliant nation, in Chemical Sector
WOCHARDT PHARMA : Co. Gives Rights Issue Details ππ
RIGHTS ISSUE SIZE : Rs 748 cr
ISSUE PRICE : Rs 225
ISSUE OPENS : 15 MARCH
ISSUE ENDS : 22 MARCH
RIGHTS ENTITLEMENT: 3 :10 ( 3 Rights Equity Shares for every 10 fully paid-up Equity Shares held by the Eligible Equity Shareholders of the Company, as on the record date)
RECORD DATE : 9 March
RIGHTS ISSUE SIZE : Rs 748 cr
ISSUE PRICE : Rs 225
ISSUE OPENS : 15 MARCH
ISSUE ENDS : 22 MARCH
RIGHTS ENTITLEMENT: 3 :10 ( 3 Rights Equity Shares for every 10 fully paid-up Equity Shares held by the Eligible Equity Shareholders of the Company, as on the record date)
RECORD DATE : 9 March
Axis Bank has signed a Memorandum of Understanding with development consulting group IPE Global to provide finance of up to $150 m to health enterprises that would otherwise not have access to affordable debt financing.